Multiple Sclerosis Comprehensive Update
This session is one of four sessions that make up the full course "Multiple Sclerosis Comprehensive Update: Overview of Clinical Management, Therapeutic Strategies and Research Trends." Learners have the option of registering for the full course or registering for the four sessions individually.
Disclosure Policy
All individuals in a position to control the content of this activity have been asked to disclose any relationship they have with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
The following planners, speakers, and content reviewers have reported relevant financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated:
NAME | COMPANY | RELATIONSHIP |
---|---|---|
Course Planners | ||
Tanuja Chitnis, MD, MA, FAAN | Novartis | Advisory Board/Committee, Consultant |
Sanofi | Advisory Board/Committee, Consultant | |
Sanofi | Research Support | |
Novartis | Research Support | |
Octave | Research Support | |
Roche Genentech | Consultant | |
I-Mab Biopharma | Research Support | |
Roche Genentech | Research Support | |
Tiziana Life Sciences | Research Support, Consultant | |
Maria Houtchens, MD, MSc | Biogen | Research Support, Consultant |
Genzyme | Research Support | |
Serono | Consultant | |
Roche | Research Support, Advisory Board/Committee | |
Novartis | Research Support | |
Course Faculty | ||
Rohit Bakshi, MD, MA | Bristol-Myers Squibb | Consultant, Research Suppor |
EMD Serono | Consultant, Research Suppor | |
Novartis | Research Support | |
Eric Klawiter, MD, MSc | Genentech | Consultant, Research Support |
Abbvie | Research Support | |
Biogen | Research Support | |
TG Therapeutics | Advisory Board/Committee | |
OM1 | Consultant | |
Intellisphere | Speaker | |
Tarun Singhal, MD, MBBS | Novartis | Research Support |
I-mab | Research Support | |
Tiziana | Consultant | |
Biohaven | Research Support | |
Kristin Galetta, MD, MSEd | GlaxoSmithKline | Consultant |
All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have reported no relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.